Risk factors
Xencor (XNCR) risk factors
Item 1A of every Xencor Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors57 risks7 new6 dropped15 reworded
Xencor expanded disclosures regarding international clinical trials, geopolitical risks involving China-based manufacturers, and potential regulatory or government shutdown delays.
Filed Feb 25, 2026 - FY2024 10-K risk factors56 risks
Clinical-stage biopharmaceutical operations rely heavily on the proprietary XmAb technology platform and partnerships. Significant ongoing operating losses and heavy reliance on external financing dictate the business trajectory.
Filed Feb 27, 2025